Cargando…

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!

Detalles Bibliográficos
Autores principales:	de Grooth, Harm-Jan S, Girbes, Armand R, Tuinman, Pieter R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273483/ https://www.ncbi.nlm.nih.gov/pubmed/25672666 http://dx.doi.org/10.1186/s13054-014-0709-4

Ejemplares similares

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials
por: de Denus, Simon, et al.
Publicado: (2016)

Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study
por: Rahhal, Alaa, et al.
Publicado: (2019)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men
por: Rasmussen, Tyler P., et al.
Publicado: (2019)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Ultra‐high dose intravenous nitroglycerin in an ESRD patient with acutely decompensated heart failure
por: Gyory, Michael, et al.
Publicado: (2021)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ibrahim, Ayman, et al.
Publicado: (2020)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Effects of intravenous furosemide plus small‐volume hypertonic saline solutions on markers of heart failure
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF
por: Ouwerkerk, Wouter, et al.
Publicado: (2022)

A structured diagnostic algorithm for patients with ARDS
por: Bos, Lieuwe Durk Jacobus, et al.
Publicado: (2023)

Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013)

Echocardiographic predictors of change in renal function with intravenous diuresis for decompensated heart failure
por: Gannon, Stephen A., et al.
Publicado: (2018)

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

The added value of hypertonic saline solution to furosemide monotherapy in patients with acute decompensated heart failure: A meta‐analysis and trial sequential analysis
por: Diaz‐Arocutipa, Carlos, et al.
Publicado: (2023)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
por: Barzegari, Hasan, et al.
Publicado: (2021)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST)
por: Hamo, Carine E., et al.
Publicado: (2021)

Acute Decompensated Heart Failure Update
por: Teerlink, John R, et al.
Publicado: (2015)

The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure
por: Shi, Jinzheng, et al.
Publicado: (2022)

Iatrogenic Decompensated Heart Failure
por: Tran, Patrick, et al.
Publicado: (2020)

Response to: MR-proADM has a good ability to predict mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: van Oers, Jos A.H., et al.
Publicado: (2022)

Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose–Response Curves in Worsening Refractory Congestive Heart Failure
por: Paterna, Salvatore, et al.
Publicado: (2015)

Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients
por: CHEN, ZHI-HAO, et al.
Publicado: (2016)

Dose of furosemide before admission predicts diuretic efficiency and long‐term prognosis in acute heart failure
por: Blázquez‐Bermejo, Zorba, et al.
Publicado: (2021)

Retracted: The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Proteomic differences among patients with heart failure taking furosemide or torsemide
por: Cooper, Lauren B., et al.
Publicado: (2022)

Multimodality imaging in decompensated heart failure
por: D’Andrea, Antonello, et al.
Publicado: (2023)

Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione
por: Kaesemeyer, Wayne, et al.
Publicado: (2021)

How long before hospital admission do the symptoms of heart failure decompensation arise?
por: Born, Maraísa Carine, et al.
Publicado: (2019)

Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure
por: Njoroge, Joyce N., et al.
Publicado: (2021)

The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis
por: Assy, Nimer, et al.
Publicado: (2006)

Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates
por: de Grooth, Harm-Jan, et al.
Publicado: (2018)

Breathing variability—implications for anaesthesiology and intensive care
por: van den Bosch, Oscar F. C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5eq67hguea38dlbklkjf8hfq4p